Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-11-2021 | COVID-19 Vaccination | Case report

Mycophenolate-mofetil/tacrolimus/tozinameran

Vaccination failure and COVID-19: case report

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference De Greef J, et al. Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy. Kidney International 100: 1131-1132, No. 5, 31 Aug 2021. Available from: URL: http://doi.org/10.1016/j.kint.2021.08.018 De Greef J, et al. Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy. Kidney International 100: 1131-1132, No. 5, 31 Aug 2021. Available from: URL: http://​doi.​org/​10.​1016/​j.​kint.​2021.​08.​018
Metadata
Title
Mycophenolate-mofetil/tacrolimus/tozinameran
Vaccination failure and COVID-19: case report
Publication date
01-11-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-06250-8

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Trastuzumab

Case report

Fingolimod

Case report

Sorafenib